Where do payers fit into this paradigm? What good is drug/device if not paid for. Q from Eve Dryer @ #ePatCon
Off-labeling of drugs and not being mentioned. "everyone forgets about us" on sickle cell disease. @TahirahAkilah #ePatCon
Sickle cell advocate @TahirahAkilah talks about pain management makes them look like drug seekers (drugs opiate based). #ePatCon
Using guidelines, @PhilBaumann only able to write compliant tweet for about 6 drugs of over 30 he looked at. #ePatCon
You know it!!! RT @LeslieRott: If patient are drugs, they would be the breakout drug of the year #ePatCon
So sad today. Just learned of death of 32 y/o cousin thru marriage who lives in Italy. Such a huge heart. Not accident, not drugs. #Tragic
Help us learn? "@PhRMA: Understanding gap among #patients as to how drugs developed, Christopher Austin of @ncats_nih_gov at #PhRMA14 #TR2 "
Is your rep supporting #cancer drug parity? Check here: HR1801 is important. Let your voice be heard.
How to fix? RT @chemoadvisor: 83% of U.S. hematologists/oncologists reported drug shortage in past 6 mo #ASCO13
Need to shift the thinking: Ben Anderson. Research is always seen as "drugs" .. new focus " implementation science" #AACR
"there is misconception that targeted drugs are less toxic" By whom?? #BCSM We needed a posse in this conversation!!!
Patient population at large is infinitely higher than those who are at public hearings re drug approval. #AACR
This is getting interesting. A bit of finger pointing re Avastin. There are docs who are still convinced it's a good drug for BC. #AACR
Difference between taking a drug off market for toxicity v. efficacy. Would prefer "conditional approval" terminology. #AACR
See what's Trending Now for @chemobrainfog